Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cancer Biomarkers : Section a of Disease Markers
|
November 2, 2016
Molecular combing: A new tool in diagnosing leukemia
Antoine Ittel, Hélène Zattara, Charlène Chaix, et al.
Thrombosis and Haemostasis
|
October 28, 2010
Increased risk of gestational vascular complications in women with low free tissue factor pathway inhibitor plasma levels out of pregnancy
Antoine Ittel, Florence Bretelle, Jean-Christophe Gris, et al.
Plos One
|
June 18, 2016
Sumoylation Inhibits the Growth Suppressive Properties of Ikaros
Apostol Apostolov, Isma Litim-Mecheri, Attila Oravecz, et al.
Genes, Chromosomes & Cancer
|
May 23, 2026
The t(X;5)(q13;q33) Translocation in Myeloid Neoplasms Is Preferentially Associated With Chronic Myelomonocytic Leukemia: A Report From the Groupe Francophone de Cytogénétique Hématologique
Florence Nguyen-Khac, Marc Muller, Agnes Daudignon, et al.
Cancers
|
April 23, 2022
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
Sylvain Garciaz, Marie-Anne Hospital, Anne-Sophie Alary, et al.
European Journal of Haematology
|
August 12, 2024
Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics
Amel Soua, Julia Gilhodes, Alexandre Iat, et al.
Leukemia Research
|
April 18, 2024
Poor prognosis of SRSF2 gene mutations in patients treated with VEN-AZA for newly diagnosed acute myeloid leukemia
Guillaume Berton, Bochra Sedaki, Erwann Collomb, et al.
British Journal of Haematology
|
December 14, 2020
Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities
Baptiste Gailllard, Pascale Cornillet-Lefebvre, Quoc-Hung Le, et al.
Blood Advances
|
October 12, 2021
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11
Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, et al.
Blood
|
September 19, 2019
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53
Elise Chapiro, Elodie Pramil, M'boyba Diop, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cancer Biomarkers : Section a of Disease Markers
|
November 2, 2016
Molecular combing: A new tool in diagnosing leukemia
Antoine Ittel, Hélène Zattara, Charlène Chaix, et al.
Thrombosis and Haemostasis
|
October 28, 2010
Increased risk of gestational vascular complications in women with low free tissue factor pathway inhibitor plasma levels out of pregnancy
Antoine Ittel, Florence Bretelle, Jean-Christophe Gris, et al.
Plos One
|
June 18, 2016
Sumoylation Inhibits the Growth Suppressive Properties of Ikaros
Apostol Apostolov, Isma Litim-Mecheri, Attila Oravecz, et al.
Genes, Chromosomes & Cancer
|
May 23, 2026
The t(X;5)(q13;q33) Translocation in Myeloid Neoplasms Is Preferentially Associated With Chronic Myelomonocytic Leukemia: A Report From the Groupe Francophone de Cytogénétique Hématologique
Florence Nguyen-Khac, Marc Muller, Agnes Daudignon, et al.
Cancers
|
April 23, 2022
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
Sylvain Garciaz, Marie-Anne Hospital, Anne-Sophie Alary, et al.
European Journal of Haematology
|
August 12, 2024
Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics
Amel Soua, Julia Gilhodes, Alexandre Iat, et al.
Leukemia Research
|
April 18, 2024
Poor prognosis of SRSF2 gene mutations in patients treated with VEN-AZA for newly diagnosed acute myeloid leukemia
Guillaume Berton, Bochra Sedaki, Erwann Collomb, et al.
British Journal of Haematology
|
December 14, 2020
Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities
Baptiste Gailllard, Pascale Cornillet-Lefebvre, Quoc-Hung Le, et al.
Blood Advances
|
October 12, 2021
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11
Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, et al.
Blood
|
September 19, 2019
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53
Elise Chapiro, Elodie Pramil, M'boyba Diop, et al.
Page
of 1